New website, 5/14
May 2014—Quantimetrix launched its new website, quantimetrix.com. The website features fast, content-rich resources with a responsive design technology.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
GI panel submitted for 510(k) clearance, 5/14
May 2014—BioFire Diagnostics submitted the FilmArray Gastrointestinal Panel to the FDA for 510(k) clearance.
QML for connectivity, 5/14
May 2014—Telcor released a software driver for the Pathfast cardiac biomarker analyzer that allows the company’s QML to automatically interface results from the analyzer to a laboratory information system and electronic medical record system.
Lynch syndrome diagnostic tests, 5/14
May 2014—Quest Diagnostics is offering new pathology and blood tests for identifying and assessing an individual’s risk of Lynch syndrome.
Distribution agreement
May 2014—Copan Diagnostics announced an agreement with Thermo Fisher Scientific to distribute the Copan WASP, a walk-away specimen processor, in the United States.
Urine specimen stabilizer, 5/14
May 2014—The Vacuette Urine CCM Tube from Greiner Bio-One is an evacuated tube, which contains a stabilizer powder that keeps the urine sample stable up to 48 hours at 20°–25°C.
Siemens, NKF enter strategic alliance, 5/14
May 2014—Siemens Healthcare and the National Kidney Foundation entered into a strategic alliance to increase awareness of the importance of albumin-to-creatinine ratio testing in high-risk individuals, with the goal of improving diagnosis and identifying kidney disease early in its course. Siemens and NKF will also help put the new clinical recommendations into practice.
Vidas C. difficile GDH, 5/14
May 2014—BioMérieux launched its Vidas C. difficile GDH for automated detection of GDH, a specific enzyme produced by C. difficile. Vidas C. difficile GDH is the first automated immunoassay cleared by the Food and Drug Administration.
Bone marrow tissue stain, 5/14
May 2014—Dako added the Jenner-Wright Giemsa stain to its Artisan Link portfolio of automated stains. The stain is designed to provide clear differentiation and detail of the hematopoietic cells in bone marrow tissue samples for the diagnosis of cancer, aplastic anemia, and myelofibrosis.
Hsp70 ELISA kit, 5/14
May 2014—Enzo Life Sciences now offers the Amp’d HSP70 High Sensitivity ELISA Kit for detecting both baseline and upregulated levels of Hsp70 (Hsp72).